title: Deep sequencing of plasma and proviral HIV-1 to establish coreceptor usage: what is the clinical impact of the quasispecies distribution?
authors.forename: Isabella
authors.initials: I
authors.lastname: Abbate
authors.forename: Gabriella
authors.initials: G
authors.lastname: Rozera
authors.forename: Emanuela
authors.initials: E
authors.lastname: Giombini
authors.forename: Gianpiero
authors.initials: G
authors.lastname: D'Offizi
authors.forename: Emanuele
authors.initials: E
authors.lastname: Nicastri
authors.forename: Pasquale
authors.initials: P
authors.lastname: Narciso
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Ippolito
authors.forename: Maria R
authors.initials: MR
authors.lastname: Capobianchi
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology*; D003510:Cyclohexanes / Q000494:pharmacology*; D015658:HIV Infections / Q000821:virology*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D015728:Receptors, HIV / Q000378:metabolism*; D014230:Triazoles / Q000494:pharmacology*; D056189:Viral Tropism; D014773:Virology / Q000379:methods*
chemical_list: D019380:Anti-HIV Agents; D003510:Cyclohexanes; D015728:Receptors, HIV; D014230:Triazoles